DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Scher HI, Jia X, Chi K, de Wit R, Berry WR, Albers P, Henick B, Waterhouse D, Ruether DJ, Rosen PJ, Meluch AA, Nordquist LT, Venner PM, Heidenreich A, Chu L, Heller G.
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.
J Clin Oncol 2011;
29: 2191-2198
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.